To determine the efficacy and safety of 1000 IU/ ml topical solution of heparin sodium versus 200 IU/G heparin sodium gel in the management of post infusion superficial thrombophlebitis.
Phase 3
Completed
- Conditions
- Health Condition 1: null- Post infusion superficial thrombophlebitis.
- Registration Number
- CTRI/2010/091/002947
- Lead Sponsor
- Troikaa Pharmaceuticals Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
a)Patients in the age group of 18-60 years
b)Patients of both sexes
c)Patients on IV infusion
d)Superficial thrombophlebitis Grade 2-4
Exclusion Criteria
a)Patients below 18 years and above 60 years of age
b)Patients on anticoagulants
c)Pregnant and lactating women
d)Patients with any contraindication to heparin
e)Mentally retarded patients
f)Unwilling patients
g)Patients with known hypersensitivity to any component of the formulation
h)Patients with grade 1 or 5 phlebitis
i)Application of other topical anti-inflammatory agent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method